{
  "@context": "https://frontierpicks.com/schemas/dossier.v1.json",
  "ticker": "CODI",
  "name": "Compass Diversified",
  "url": "https://frontierpicks.com/dossiers/CODI/",
  "json_url": "https://frontierpicks.com/dossiers/CODI.json",
  "status": "DORMANT",
  "current_conviction": "MEDIUM",
  "graded_conviction": null,
  "archetype": {
    "code": "a4",
    "n": 4
  },
  "current_thesis": "Q2 (2026-08-10) reframed the name: adj EPS $(0.09) missed $0.09 est, but Subsidiary Adj EBITDA rose 12.6% to $91.5M and covenant leverage fell 5.3x to 4.8x. TD Cowen went $12.50→$18. Riley upgraded to Buy at $15 on 2026-08-11; three insiders bought 2026-08-12/13 up to $12.42. Price hit a new high of $12.71 then faded 8.1% — the re-rating is being tested.",
  "invalidation_trigger": "A weekly close below $11 returns price beneath its 2026-08-07 pre-print reference and gives back the entire post-Q2 advance; secondary condition, the FY2026 Subsidiary Adjusted EBITDA outlook of $320-365M being cut at the Q3 print with no subsidiary sale process disclosed.",
  "catalyst_date": null,
  "outcome": "OPEN",
  "outcome_date": null,
  "invalidation_fired": null,
  "themes": [
    "m-and-a-special-situations",
    "consumer-discretionary-rotation"
  ],
  "tags": [],
  "sources": [],
  "notes": [
    "Common distribution remains suspended; only Series A/B/C preferreds are current, with $9.7M paid in Q2 2026. No yield floor under the common.",
    "Externally managed by Compass Group Management LLC. The 2026-07-13 Ninth Amended MSA cuts fees but does not internalize management; new terms start 2027-01-01.",
    "SEC/DOJ enforcement exposure and securities class actions arising from the Lugano fraud remain open, undated and without a disclosed reserve figure.",
    "Leverage of ~4.8x at 2026-06-30 is the covenant-purposes calculation reported by the company, not a GAAP debt/EBITDA figure.",
    "CEO Elias Sabo retires 2026-12-31; COO Zach Sawtelle has been in seat since 2026-06-10 with deleveraging stated as the priority.",
    "Q2 GAAP net income of $81.9M includes a $182.3M Sterno gain and a $58.0M Lugano receivable writedown; it is not a run-rate earnings figure."
  ],
  "body_markdown": "\n_Refresh of coverage first published 2026-04-19; last written 2026-08-08. Price reference: the 2026-08-21 close of $11.68._\n\n## CODI — Compass Diversified, Inc.\n\n## Current Thesis\nThe binary carried in the prior note resolved on 2026-08-10, and it resolved in an awkward shape: the headline missed, the internals improved. Net revenue came in at $424.0M, down 11.4% year over year and short of the $425.35M consensus, and adjusted EPS was $(0.09) against a $0.09 estimate. Underneath that, Subsidiary Adjusted EBITDA rose 12.6% to $91.5M, covenant leverage fell to roughly 4.8x at 2026-06-30 from 5.3x at 2026-03-31, more than $280M of Sterno proceeds went to debt, and the FY2026 Subsidiary Adjusted EBITDA outlook of $320–365M was maintained. The market graded the balance sheet, not the EPS line: on 2026-08-11 TD Cowen kept Buy and moved its target from $12.50 to $18, and B. Riley upgraded from Neutral to Buy with a target from $11 to $15. Price made a new 52-week high at $12.71 and has since faded to $11.68, 8.1% below it.\n\nThe narrative leg is unchanged in kind but stronger in evidence: a holdco trading below the private-market value of its parts, closing the gap through asset sales, debt reduction and a signed fee cut. What changed is that the deleveraging claim now has a covenant number attached to it, and that the people running the company bought stock with their own money above where it trades today.\n\n## Bull Case\n- **Leverage moved, measurably** — covenant leverage approximately 4.8x at 2026-06-30 versus 5.3x at 2026-03-31, senior secured net leverage 0.66x, with more than $280M of Sterno proceeds applied to debt (Q2 2026 release, 2026-08-10). The deleveraging argument is now a reported ratio rather than an intention.\n- **Operating trend is better than the headline** — Subsidiary Adjusted EBITDA of $91.5M, up 12.6% year over year, with Branded Consumer at $69.3M (+24.2%). Excluding Lugano and the divested Sterno operations, revenue of $410.6M was roughly flat year over year, against a reported decline of 11.4% (Q2 2026 release, 2026-08-10).\n- **Sell-side repriced the same day** — on 2026-08-11 TD Cowen raised its target from $12.50 (set 2026-07-16) to $18 and B. Riley upgraded to Buy at $15, the same shop that carried a $10.50 target on 2026-04-07. B. Riley's case leans partly on a full or partial subsidiary sale by end-2026.\n- **Insiders bought into the move, not out of it** — All of it is above the 2026-08-21 close of $11.68.\n- **Fee reform is contracted** — the 2026-07-13 Ninth Amended MSA cuts the base fee from 2.00% of Adjusted Net Assets to 1.25% on the first $3B, caps 2027 base fees at $30M, and is estimated by the company at $19–22M of lower 2027 fees.\n- **Maturity wall pushed out** — subsequent to quarter-end the senior credit facility was amended to extend all outstanding term loans and revolving commitments to 2028-01-12.\n\n## Bear Case\n- **The cash-earnings line is negative** — adjusted EPS of $(0.09) against a $0.09 estimate on 2026-08-10. GAAP net income from continuing operations of $81.9M is a construct of a $182.3M gain on the Sterno food-service sale offset by a $58.0M reduction in the fair value of the Lugano receivable, and is not a run-rate.\n- **The Lugano markdown is live, not settled** — $58.0M of fair value came out of that receivable in Q2 alone. The 2026-06-24 settlement framework still produces an undetermined recovery, subject to bankruptcy court confirmation.\n- **Industrial is going the wrong way** — segment Adjusted EBITDA of $22.3M in Q2, down 12.8% year over year, while Branded Consumer carried the quarter.\n- **Liquidity headroom shrank as part of the extension** — aggregate revolving commitments were cut from $100.0M to $54.0M in the post-quarter amendment, against $87.4M of cash and roughly $97M of revolver availability reported at 2026-06-30.\n- **Nothing from the fee cut reaches 2026** — the revised MSA economics take effect 2027-01-01. Q3 and Q4 2026 are reported on the old 2.00% formula.\n- **Common holders still receive nothing** — $9.7M of preferred distributions were paid in Q2 2026 and no common distribution was made. There is no yield support under the common.\n- **The enforcement tail is unquantified** — SEC/DOJ exposure and securities class actions arising from the Lugano fraud remain open and undated, with no disclosed reserve figure.\n\n## Setup & Price Structure\nThe narrative is **accelerating**, dated to 2026-08-11 through 2026-08-13 — two target changes on the same session (TD Cowen $12.50→$18, B. Riley Neutral→Buy $11→$15), a fresh 52-week high at $12.71, and three separate insiders buying open-market stock across 2026-08-12/13. That is new attention and widening participation, from a name whose prior news flow in this feed was Benzinga overbought-RSI listicles in late March and mid-April 2026.\n\nThe counter-evidence to that label is in the tape itself. From the 2026-08-07 close of $11.00, price ran to the $12.71 high and has given back 8.1% to close at $11.68 on 2026-08-21. Over three months the shares are up 1.9%, so effectively the entire year-to-date structure is the last two weeks plus a round trip. RSI(14) of 62.1 at 2026-08-21 says the fade has not broken the trend — momentum is still positive eight percent below the high, which is a different condition from a failed breakout.\n\nStructure to watch: the $11.00 area is the last pre-print reference, and the early-July low near $10.08 (2026-07-08) is the base the whole post-amendment leg was built from. The zone between the current close and $11.00 is where the market decides whether 2026-08-10 was a re-rating or a headline pop.\n\nCrowding and positioning observables, stated without a verdict: no earnings date inside the next 30 days, so nothing compresses positioning near-term; insider flow is buying rather than selling into strength, and at prices ($11.99–$12.45 implied by the Form 4 values) above the current close; no equity issuance has been announced into the move; the credit amendment reduced committed revolver capacity rather than raising fresh capital; and the published target range widened from around $12.50 to $15–$18, which places the current close 22% below the lower of the two new targets.\n\n## Catalyst Calendar (next 30 days)\n\n- **No confirmed company-dated event falls inside the window through ~2026-09-21.** The Q2 print (2026-08-10) and both analyst actions (2026-08-11) are behind. Stated plainly so the absence is not mistaken for an unresearched gap.\n- **~2026-10-01 (est.)** — Q3 preferred distribution declaration, following the pattern of the Q2 declaration on 2026-07-01 (record 2026-07-15, payable 2026-07-30). Outside 30 days.\n- **~2026-11-02 (est., not yet announced)** — Q3 2026 results. First quarter to show whether the 12.6% Subsidiary Adjusted EBITDA growth repeats without a divestiture gain, and whether the $320–365M FY2026 outlook holds into the final quarter.\n- **2026-12-31** — CEO Elias Sabo retires;\n- **2027-01-01** — revised MSA fee and incentive terms take effect; the estimated $19–22M annual saving starts appearing in reported results.\n\n## Elapsed catalysts\n\n- **~2026-Q4 (est.)** — Lugano plan of liquidation confirmation hearing, court-scheduled and not yet announced. Converts the 2026-06-24 settlement framework into an actual number, against a receivable already written down $58.0M in Q2. *(passed 63d ago)*\n\n## What Would Change Our Mind\nThe structure that has to hold is the post-print advance itself. The 2026-08-10 report was received as a balance-sheet event, so the thesis breaks if the balance-sheet evidence stops compounding: a Q3 covenant leverage reading back above the 5.3x of 2026-03-31, or an FY2026 Subsidiary Adjusted EBITDA outlook cut below $320–365M, would remove the reason both targets were raised on 2026-08-11.\n\nOn price, a weekly close below $11 returns the stock beneath its 2026-08-07 pre-print reference and gives back the whole re-rating; a weekly close below $10 would take out the base built off the 2026-07-08 low and put the narrative in the failed-catalyst bucket regardless of the target range.\n\nTwo non-price conditions would also flip the read. First, the B. Riley case rests partly on a further full or partial subsidiary sale by end-2026 — if the Q3 call discloses no active process, the divestiture leg of the story is a 2027 problem, not a 2026 one. Second, any disclosed reserve or settlement figure against the SEC/DOJ matters or the securities class actions would attach a number to the one liability currently carried at zero in every model.\n\nThe condition that would raise conviction rather than break it: a second consecutive quarter of Subsidiary Adjusted EBITDA growth without divestiture gains, alongside leverage below 4.5x.\n\n## Correlation Notes\n- **Idiosyncratic first.** The 2026-08-11 move was driven by two broker actions on the same company; index beta explains little of a name whose three-month price change is +1.9% while carrying a two-week 8.1% drawdown from a fresh high.\n- **Consumer discretionary is the operating exposure.** Branded Consumer produced $69.3M of the $91.5M Q2 Subsidiary Adjusted EBITDA, through 5.11 Tactical, BOA Technology, Ergobaby, Velocity Outdoor and The Honey Pot. Discretionary demand data reads through here more than any financials-sector comp, despite the sector tag applied by the screeners quoted in the March and April 2026 Benzinga items.\n- **Rate and credit sensitivity is structural at 4.8x.** With term loans and revolver extended to 2028-01-12 and committed revolver capacity reduced to $54.0M, the cost and availability of leveraged credit is a direct input to the deleveraging path.\n- **Private-market M&A bid sets the math.** The Sterno transaction at $292.5M enterprise value (announced 2026-03-30, closed 2026-05-04) is the reference point for what the remaining subsidiaries fetch. A softer sponsor exit market compresses the sum-of-the-parts argument that both raised targets rest on.\n- **The preferreds trade separately.** Series A/B/C are current and were paid $9.7M in Q2 2026; they follow yield, not the equity's discount-narrowing story, and their behaviour is not a read on the common.",
  "first_seen": "2026-04-19",
  "last_analyzed": "2026-08-22T07:40:30+00:00",
  "last_synthesized": "2026-08-22",
  "last_update_source": "watchlist_research",
  "license": "Content © FrontierPicks. Cite the canonical URL."
}